T

Teyi Pharmaceutical Group Co Ltd
SZSE:002728

Watchlist Manager
Teyi Pharmaceutical Group Co Ltd
SZSE:002728
Watchlist
Price: 8.85 CNY -4.53%
Market Cap: 4.5B CNY
Have any thoughts about
Teyi Pharmaceutical Group Co Ltd?
Write Note

Teyi Pharmaceutical Group Co Ltd
Short-Term Debt

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Teyi Pharmaceutical Group Co Ltd
Short-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Short-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
T
Teyi Pharmaceutical Group Co Ltd
SZSE:002728
Short-Term Debt
ÂĄ477.4m
CAGR 3-Years
-1%
CAGR 5-Years
-8%
CAGR 10-Years
21%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Short-Term Debt
ÂĄ0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Short-Term Debt
ÂĄ1.1B
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
60%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Short-Term Debt
ÂĄ249m
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
37%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Short-Term Debt
ÂĄ4.1B
CAGR 3-Years
10%
CAGR 5-Years
20%
CAGR 10-Years
21%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Short-Term Debt
ÂĄ318.9m
CAGR 3-Years
23%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Teyi Pharmaceutical Group Co Ltd
Glance View

Market Cap
4.5B CNY
Industry
Pharmaceuticals

Teyi Pharmaceutical Group Co., Ltd. engages in the pharmaceutical manufacturing and pharmaceutical health industry. The company is headquartered in Jiangmen, Guangdong and currently employs 1,200 full-time employees. The company went IPO on 2014-07-31. The firm primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The firm's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.

Intrinsic Value
11.64 CNY
Undervaluation 24%
Intrinsic Value
Price
T

See Also

What is Teyi Pharmaceutical Group Co Ltd's Short-Term Debt?
Short-Term Debt
477.4m CNY

Based on the financial report for Sep 30, 2024, Teyi Pharmaceutical Group Co Ltd's Short-Term Debt amounts to 477.4m CNY.

What is Teyi Pharmaceutical Group Co Ltd's Short-Term Debt growth rate?
Short-Term Debt CAGR 10Y
21%

Over the last year, the Short-Term Debt growth was 22%. The average annual Short-Term Debt growth rates for Teyi Pharmaceutical Group Co Ltd have been -1% over the past three years , -8% over the past five years , and 21% over the past ten years .

Back to Top